🔗 Permalink

Inventor profile of:

Donna Gutterman

City:

Raleigh, North Carolina

Country:

United States

Published Applications:

Last publication date:

2026-03-26

Top Assignees for applications by Donna Gutterman

The entities that hold a legal rights for patent applications filed by inventor Gutterman Donna:

ZYNERBA PHARMACEUTICALS, INC. 27 Devon, PA United States
HARMONY BIOSCIENCES MANAGEMENT, INC. 16 Plymouth Meeting, PA United States

Recent patent applications by Gutterman Donna

Donna Gutterman from Raleigh, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-26

US20260083758A1

Human necessities

TREATMENT OF SYNGAP1 ENCEPHALOPATHY

#2 | 2026-02-05

US20260034151A1

Human necessities

TREATMENT OF FRAGILE X SYNDROME AND AUTISM SPECTRUM DISORDER WITH CANNABIDIOL

#3 | 2025-11-06

US20250339450A1

Human necessities

TREATMENT OF SYNGAP1 ENCEPHALOPATHY

#4 | 2025-10-02

US20250302734A1

Human necessities

SYNTHETIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS

#5 | 2025-09-18

US20250288539A1

Human necessities

TREATMENT OF FRAGILE X SYNDROME AND AUTISM SPECTRUM DISORDER WITH CANNABIDIOL

#6 | 2025-08-28

US20250268843A1

Human necessities

METHODS OF TREATMENT OF OSTEOARTHRITIS WITH TRANSDERMAL CANNABIDIOL GEL

#7 | 2025-07-03

US20250213465A1

Human necessities

SYNTHETIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS

#8 | 2025-06-26

US20250205174A1

Human necessities

TREATMENT OF 22Q11.2 DELETION SYNDROME WITH CANNABIDIOL

#9 | 2025-06-19

US20250195451A1

Human necessities

TREATMENT OF SYNGAP1 ENCEPHALOPATHY

#10 | 2025-06-05

US20250177322A1

Human necessities

TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL

#11 | 2025-05-01

US20250134833A1

Human necessities

TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL

#12 | 2025-05-01

US20250134832A1

Human necessities

TREATMENT OF AUTISM WITH CANNABIDIOL

#13 | 2024-09-19

US20240307418A1

Human necessities

TREATMENT OF SLEEP APNEA WITH CBD

#14 | 2024-06-13

US20240189255A1

Human necessities

METHODS OF TREATMENT OF OSTEOARTHRITIS WITH TRANSDERMAL CANNABIDIOL GEL

#15 | 2024-05-09

US20240148669A1

Human necessities

METHODS OF TREATMENT OF OSTEOARTHRITIS WITH TRANSDERMAL CANNABIDIOL GEL

#16 | 2024-01-11

US20240009210A1

Human necessities

Cannabidiol for the Treatment of Refractory Seizures

#17 | 2023-12-28

US20230414533A1

Human necessities

Treatment of fragile X syndrome with cannabidiol

#18 | 2023-11-16

US20230364028A1

Human necessities

Treatment of autism with cannabidiol

#19 | 2023-02-23

US20230059709A1

Human necessities

TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL

#20 | 2023-01-26

US20230024756A1

Human necessities

Treatment of 22Q11.2 deletion syndrome with cannabidiol

#21 | 2023-01-05

US20230000793A1

Human necessities

TREATMENT OF 22Q11.2 DELETION SYNDROME WITH CANNABIDIOL

#22 | 2023-01-05

US20230000792A1

Human necessities

TREATMENT OF 22Q11.2 DELETION SYNDROME WITH CANNABIDIOL

#23 | 2023-01-05

US20230000790A1

Human necessities

Treatment of Fragile X Syndrome with cannabidiol

#24 | 2022-07-14

US20220218625A1

Human necessities

TREATMENT OF BEHAVIORAL IMPAIRMENT IN DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY

#25 | 2022-03-31

US20220096396A1

Human necessities

TREATMENT OF AUTISM WITH CANNABIDIOL

#26 | 2021-12-02

US20210369643A1

Human necessities

TREATMENT OF FRAGILE X SYNDROME AND AUTISM SPECTRUM DISORDER WITH CANNABIDIOL

#27 | 2021-03-18

US20210077421A1

Human necessities

TREATMENT OF SYNGAP1 ENCEPHALOPATHY

#28 | 2021-02-04

US20210030665A1

Human necessities

SYNTHETIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS

#29 | 2020-11-19

US20200360299A1

Human necessities

Treatment of Fragile X Syndrome with cannabidiol

#30 | 2020-07-09

US20200214995A1

Human necessities

TREATMENT OF AUTISM WITH CANNABIDIOL

#31 | 2020-06-18

US20200188324A1

Human necessities

Treatment of 22Q11.2 deletion syndrome with cannabidiol

#32 | 2020-06-04

US20200170963A1

Human necessities

METHODS OF TREATMENT OF OSTEOARTHRITIS WITH TRANSDERMAL CANNABIDIOL GEL

#33 | 2020-01-30

US20200030255A1

Human necessities

Treatment of fragile x syndrome with cannabidiol

#34 | 2019-08-29

US20190262280A1

Human necessities

Treatment of autism with cannabidiol

#35 | 2019-06-06

US20190167605A1

Human necessities

Treatment of fragile X syndrome with cannabidiol

#36 | 2019-04-25

US20190117588A1

Human necessities

Treatment of autism with cannabidiol

#37 | 2019-03-21

US20190083388A1

Human necessities

SYNTHENTIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS

#38 | 2019-02-26

US16144632

Human necessities

Treatment of fragile X syndrome with cannabidiol

InventorID:

2456930 ⎘